×
戻る Agenda
Session 4, Track C: Translate Policy into Practice: Applying Health Canada's 2026 Pharmacovigilance Guidance
Session Chair(s)
Yulia Vasianovich, PhD, RAC
Scientific Evaluator, Marketed Health Products Directorate, Health Canada, Canada
Daniel Greco, PharmD, MS, RPh
Associate Director of Patient Safety, Bristol-Myers Squibb Company, Canada
Session 4, Track C: Translate Policy into Practice: Applying Health Canada's 2026 Pharmacovigilance Guidance